Hobbs Group Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$562K Buy
469
+41
+10% +$41.9K 0.15% 98
2026
Q1
$394K Buy
428
+8
+2% +$8.11K 0.12% 116
2025
Q4
$451K Buy
+420
New +$402K 0.14% 106
2025
Q1
Sell
-272
Closed -$210K 155
2024
Q4
$210K Buy
272
+13
+5% +$10.8K 0.08% 137
2024
Q3
$229K Hold
259
0.08% 131
2024
Q2
$234K Buy
+259
New +$207K 0.09% 130
2023
Q4
$167K Buy
+286
New +$167K 0.07% 131

Other funds holding LLY

Hobbs Group Advisors's LLY Position: Q2 2026 in Review

Hobbs Group Advisors increased its Eli Lilly (LLY) stake by 9.6% in Q2 2026, buying an estimated $41.9K and bringing the position to 469 shares worth $562K. The position accounts for 0.15% of the portfolio, ranked #98.

Hobbs Group Advisors first reported a position in LLY in Q4 2023 and has held it in 7 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hobbs Group Advisors held 469 shares of Eli Lilly worth $562K as of Q2 2026.
  • Hobbs Group Advisors bought 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 0.15% of Hobbs Group Advisors's portfolio in Q2 2026, its #98 holding.
  • Hobbs Group Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 7 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hobbs Group Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.